Actonel
Product Images NDC 54868-6069

12 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Actonel (NDC 54868-6069). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (05985725 417c 44f4 9e38 4fed7cdfdaad 01)

Chemical Structure (05985725 417c 44f4 9e38 4fed7cdfdaad 01)
Chemical structure diagram of the active ingredient in Actonel as displayed, showing molecular formula components including phosphate groups, hydroxyl groups, and a pyridine ring, along with molecular weights for anhydrous and hemi-pentahydrate forms.*
FDA Label Image

Figure 1 (05985725 417c 44f4 9e38 4fed7cdfdaad 02)

Figure 1 (05985725 417c 44f4 9e38 4fed7cdfdaad 02)
A bar chart comparing the percentage of patients with fractures at various body sites for ACTONEL 5 mg versus placebo. The chart includes data for All sites, Wrist, Humerus, Hip, Pelvis, Leg, and Clavicle, showing a visual comparison between the two groups.*
FDA Label Image

Figure 2 (05985725 417c 44f4 9e38 4fed7cdfdaad 03)

Figure 2 (05985725 417c 44f4 9e38 4fed7cdfdaad 03)
A bar graph comparing mean percentage changes in bone mineral density (BMD) with standard error (SE) at three sites: Lumbar Spine, Femoral Neck, and Femoral Trochanter. It contrasts results between placebo and Actonel 5 mg groups, with sample sizes indicated above each bar.*
FDA Label Image

Figure 3 (05985725 417c 44f4 9e38 4fed7cdfdaad 04)

Figure 3 (05985725 417c 44f4 9e38 4fed7cdfdaad 04)
A bar graph comparing mean percent change in bone mineral density (BMD) plus or minus standard error of the mean (SEM) at the lumbar spine, femoral neck, and femoral trochanter between placebo and ACTONEL 5 mg groups. Sample sizes for each group at each site are indicated.*
FDA Label Image

Figure 4 (05985725 417c 44f4 9e38 4fed7cdfdaad 05)

Figure 4 (05985725 417c 44f4 9e38 4fed7cdfdaad 05)
A bar graph comparing mean percentage change in bone mineral density (BMD) at three anatomical sites—lumbar spine, femoral neck, and femoral trochanter—between Placebo and Actonel 5 mg groups. The graph includes sample sizes (n) for each group and site, showing higher BMD increases with Actonel 5 mg compared to placebo across all sites.*
FDA Label Image

Figure 5 (05985725 417c 44f4 9e38 4fed7cdfdaad 06)

Figure 5 (05985725 417c 44f4 9e38 4fed7cdfdaad 06)
A bar graph comparing the incidence percentages between Placebo and ACTONEL 5 mg groups across three categories: Patients Continuing Glucocorticoid Treatment, Patients Initiating Glucocorticoid Treatment, and Combined. Each category shows incidence rates for both treatment groups with sample sizes indicated above the bars.*
FDA Label Image

Figure 6 (05985725 417c 44f4 9e38 4fed7cdfdaad 07)

Figure 6 (05985725 417c 44f4 9e38 4fed7cdfdaad 07)
A line graph comparing the percentage change over time in a measured variable for Didronel 400 mg and Actonel 30 mg treatments. The x-axis represents visit days from 0 to 540, divided into Treatment, Follow-Up, and Extended Follow-Up phases. The y-axis shows percentage change, ranging from -120% to 20%. Data points with error bars and sample sizes (n) for each time point are included.*
FDA Label Image

Warner Chilcott Logo (05985725 417c 44f4 9e38 4fed7cdfdaad 08)

FDA Label Image

Warner Chilcott Logo (05985725 417c 44f4 9e38 4fed7cdfdaad 09)

FDA Label Image

Principal Display Panel (150 mg)

Principal Display Panel (150 mg)
Label for Actonel 150 mg tablets distributed by Physicians Total Care, Inc. The label includes the NDC number 54868-6069-0, lot number 0000, and an expiration date of 01/60. The label also notes the medication was manufactured by NewRich Pharmaceuticals, Inc. with a visible barcode beneath the text.*
FDA Label Image

Principal Display Panel (35 mg)

Principal Display Panel (35 mg)
Label for Actonel 35 mg tablets, distributed by Physicians Total Care, Inc. The label includes lot number 0000 and an expiration date of 01/60. It also shows a barcode and the distributor's address in Tulsa, OK, as well as the manufacturer Norwich Pharmacal Co., Inc., North Norwich, NY.*
FDA Label Image

Principal Display Panel (5 mg Label)

Principal Display Panel (5 mg Label)
Label for Actonel 5 mg tablets distributed by Physicians Total Care, Inc. The label shows the lot number, expiration date (01/60), and includes a barcode. It also notes manufacturing by North Norwich Pharmaceuticals, Inc., North Norwich, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.